NCT01356225View on ClinicalTrials.gov

A Single-dose Study of Intranasal Ketorolac in the Treatment of Pain Secondary to Dental Impaction Surgery

PHASE2CompletedINTERVENTIONAL

Enrollment

80

Participants

Timeline

Start Date

February 29, 2004

Primary Completion Date

March 31, 2004

Conditions

PainDental Impaction

Interventions

DRUG

Ketorolac tromethamine

30 mg Intranasal (2 x 100 uL of a 15% solution), single dose

DRUG

Placebo

IN placebo

Trial Locations (1)

Unknown

Austin Oral Surgery - PPD Development, Austin

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Egalet Ltd

INDUSTRY